Exhibit 21.1

Subsidiaries of Sanara MedTech Inc.

The following is a list of subsidiaries of Sanara MedTech Inc., a Texas corporation (the “Company”), as of December 31, 2023, the states in which they are organized and the Company’s percentage ownership of the issued and outstanding stock or other equity interests for each entity. The names of particular subsidiaries may be omitted if the unnamed subsidiaries, considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary as of the end of the year covered by the annual report on Form 10-K of which this Exhibit 21.1 forms a part. (See the definition of “significant subsidiary” in Rule 1-02(w) (17 CFR 210.1-02(w)) of Regulation S-X.)

Name of Subsidiary	State of Incorporation	Direct or Indirect Ownership Percentage
Cellerate, LLC	Texas		100	%
Wound Care Innovations, LLC	Nevada		100	%
Sanara Biologics, LLC	Texas		100	%
Rochal Technologies, LLC	Texas		100	%
United Wound and Skin Solutions, LLC	Delaware		100	%
Precision Healing, LLC	Delaware		100	%(1)
Pixalere Healthcare USA, LLC	Delaware		73	%(2)
Scendia Biologics, LLC	Delaware		100	%
Sanara MedTech Applied Technologies, LLC	Texas		100	%
Sanara Collagen Peptides, LLC	Delaware		90	%

(1) Ownership of Precision Healing, LLC is held indirectly through United Wound and Skin Solutions, LLC, a wholly owned subsidiary of the Company.

(2) Ownership of Pixalere Healthcare USA, LLC is held indirectly through United Wound and Skin Solutions, LLC, a wholly owned subsidiary of the Company.